Functional analyses of mutations in HEPACAM causing megalencephalic leukoencephalopathy

Hum Mutat. 2014 Oct;35(10):1175-8. doi: 10.1002/humu.22622. Epub 2014 Aug 18.

Abstract

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare type of leukodystrophy characterized by white matter edema. Autosomal-recessive mutations in MLC1 cause MLC type 1, and autosomal-recessive or dominant mutations in HEPACAM (also called GLIALCAM) cause MLC type 2A and type 2B, respectively. The role of MLC1 and HEPACAM is unknown, although they have been related with the processes of cell-volume regulation and potassium siphoning by astrocytes. Previous studies with some of the mutations identified in HEPACAM showed that most of them are associated with a trafficking defect. Here, we analyzed biochemically and functionally most mutations identified up-to-date in HEPACAM. Our results allow classifying the effect of mutations in different subtypes and we indicate different cellular mechanisms that lead to MLC pathogenesis.

Keywords: GLIALCAM; HEPACAM; astrocyte; chloride channels; leukodystrophy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Brain / metabolism
  • Cell Cycle Proteins
  • Cells, Cultured
  • Chloride Channels / genetics
  • Cysts / genetics*
  • Cysts / metabolism
  • Gene Knockout Techniques
  • HeLa Cells
  • Hereditary Central Nervous System Demyelinating Diseases / genetics*
  • Hereditary Central Nervous System Demyelinating Diseases / metabolism
  • Humans
  • Mice
  • Mutation*
  • Proteins / genetics*
  • Proteins / metabolism

Substances

  • Cell Cycle Proteins
  • Chloride Channels
  • HEPACAM protein, human
  • Proteins

Supplementary concepts

  • Megalencephalic leukoencephalopathy with subcortical cysts